VAXXA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.765 SEK | 0.00% |
|
-1.29% | -30.45% |
| 04-10 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-23 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 1.32M 125K 9.86M | Sales 2022 | 45.68M 4.33M 341M | Capitalization | 12.98M 1.23M 96.87M |
|---|---|---|---|---|---|
| Net income 2021 | -12M -1.14M -89.56M | Net income 2022 | -51M -4.84M -381M | EV / Sales 2021 | 14.4 x |
| Net cash position 2021 | 4.69M 445K 35.02M | Net cash position 2022 | 1.01M 95.32K 7.5M | EV / Sales 2022 | 0.26 x |
| P/E ratio 2021 |
-1.95
x | P/E ratio 2022 |
-0.25
x | Employees | 5 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 week | -1.29% | ||
| Current month | -1.29% | ||
| 1 month | -15.47% | ||
| 3 months | -13.07% | ||
| 6 months | -4.38% | ||
| Current year | -30.45% |
1 week
0.74
0.86
1 month
0.680.86
Current year
0.681.30
1 year
0.605.30
3 years
0.6072.70
5 years
0.60195.50
10 years
0.601 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Karl Frindberg
CEO | Chief Executive Officer | 53 | 31/12/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Per Hägerö
CHM | Chairman | 52 | 31/12/15 |
Milad Pournouri
BRD | Director/Board Member | 30 | - |
Oliver Aleksov
BRD | Director/Board Member | 30 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/06/24 | 0.765 | 0.00% | 56,526 |
| 05/06/24 | 0.765 | +0.66% | 1,347 |
| 04/06/24 | 0.76 | +0.66% | 16,193 |
| 03/06/24 | 0.755 | -2.58% | 55,242 |
End-of-day quote NORDIC GROWTH MARKET, June 06, 2024
More quotes- Stock Market
- Equities
- VAXXA Stock